Questions raise on Kejriwal govt’s education model; professors and non-teaching staff of 12 colleges are in miserable condition
A sit-in protest was staged by Delhi BJP MLAs outside Chief Minister and Aam Admi Party head Arvind Kejriwal‘s residence to protest against the non-payment of salaries and allowances for the last five months in 12 colleges of the Delhi University that are managed by the AAP government.
The BJP MLAs demanded that the UGC should take over all these colleges as the “Kejriwal government is not giving grants to these colleges”. They also raised questions on the Kejriwal government’s education model, arguing that professors and non-teaching staff of these 12 colleges are in “miserable condition”.
Bidhuri said that the development of these 12 colleges has come to a complete halt. Even the staff is not getting medical facilities, and all other allowances have also been stopped.
He further said that in these 12 colleges managed by the Delhi government, there are guest teachers, contract employees, and temporary employees, who hardly get Rs.12,000 to Rs.15,000 per month. “Imagine what would be their condition if they were not being paid their salaries for 5 months.”
He said that the staff of these 12 colleges are “now suffering badly and the only permanent solution is that the UGC should take over these colleges as the Kejriwal government has completely failed in managing these colleges”.
The protest, led by Leader of Opposition Ramvir Singh Bidhuri, was attended by MLAs Mohan Singh Bisht, Omprakash Sharma, Anil Vajpayee, Ajay Mahawar, and Abhay Verma.
[With Inputs from IANS]
PGurus is now on Telegram. Click here to join our channel and stay updated with all the latest news and views
For all the latest updates, download PGurus App.
- Lalit Modi plans to sue Rahul Gandhi in UK court over ‘fugitive’ jibe - March 30, 2023
- Traders’ body CAIT seeks empowered Regulatory Authority to monitor & regulate e-commerce - March 30, 2023
- Centre exempts import duty on drugs, food for special medical purposes for personal use to treat rare diseases - March 30, 2023